Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment ; volume:214 ; number:4 ; day:19 ; month:11 ; year:2010 ; pages:779-789 ; date:4.2011
Psychopharmacology ; 214, Heft 4 (19.11.2010), 779-789, 4.2011
- Creator
-
Ersche, Karen D.
Roiser, Jonathan P.
Lucas, Mark
Domenici, Enrico
Robbins, Trevor W.
Bullmore, Edward T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-010-2087-1
- URN
-
urn:nbn:de:101:1-2019062200360977427820
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ersche, Karen D.
- Roiser, Jonathan P.
- Lucas, Mark
- Domenici, Enrico
- Robbins, Trevor W.
- Bullmore, Edward T.
- SpringerLink (Online service)
Other Objects (12)
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
Discriminative learning occasioned by the administration of a dopamine agonist
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats
Central and peripheral dopamine receptors : biochemistry and pharmacology
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
Discriminative learning occasioned by the administration of a dopamine agonist
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats
Central and peripheral dopamine receptors : biochemistry and pharmacology
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
Discriminative learning occasioned by the administration of a dopamine agonist
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats
Central and peripheral dopamine receptors : biochemistry and pharmacology
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas